Stantec Inc (STN) is not a strong buy for a beginner, long-term investor at this moment. While the stock shows stable technical indicators and positive analyst ratings, the lack of significant positive catalysts, weak recent financial performance, and no proprietary trading signals suggest holding off on immediate investment.
The MACD is positive at 0.582, indicating bullish momentum, but it is contracting. RSI at 55.878 is neutral, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting indecision. Key support is at 86.077, and resistance is at 91.005. The stock is trading near its pivot at 88.541, indicating a lack of strong directional momentum.

Analyst ratings remain positive with multiple Outperform ratings and price target increases from CIBC and RBC Capital. The stock is trading pre-market at $89.34, slightly above the pivot point.
No recent news or significant trading trends from hedge funds or insiders. Financial performance in Q4 2025 showed a decline in net income (-4.18% YoY), EPS (-4.65% YoY), and gross margin (-3.82% YoY). Congress trading data is unavailable. Stock trend analysis indicates a potential short-term decline (-1.45% in the next week, -2.67% in the next month).
In Q4 2025, revenue increased by 10.91% YoY to $1.6397 billion, but net income dropped to $93.9 million (-4.18% YoY). EPS also declined to 0.82 (-4.65% YoY), and gross margin fell to 48.14 (-3.82% YoY).
Analyst sentiment remains positive overall. Recent upgrades include CIBC raising the price target to C$173 and RBC Capital raising it to C$175, both maintaining Outperform ratings. However, Scotiabank and Stifel recently lowered their price targets, citing potential concerns.